Iambic Therapeutics is a clinical-stage life-science and technology company that develops novel medicines through an AI-driven discovery and development platform. Founded in 2020 and based in San Diego, Iambic combines advanced artificial intelligence capabilities with extensive drug discovery expertise. The platform has achieved remarkable efficiency in delivering new drug candidates to human clinical trials, targeting various classes and mechanisms of action. Iambic's pipeline includes both promising internal projects and partnerships that address significant unmet medical needs. The company's ethos is grounded in diversity and inclusion, fostering a collaborative environment where a wide range of talents contribute to therapeutic innovation.